D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.58% |
| 2 | Consumer Discretionary | 13.65% |
| 3 | Healthcare | 12.98% |
| 4 | Industrials | 7.3% |
| 5 | Financials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Fulton Financial
FULT
$4.67B
| $1.05M | ﹤0.01% |
+64,219
| New | +$1.06M |
|
|
CNR
2602
Core Natural Resources Inc
CNR
$4.16B
| $1.05M | ﹤0.01% |
39,447
-5,440
| -12% | -$163K |
|
2603
Universal Health Services
UHS
$9.64B
| $1.05M | ﹤0.01% |
8,042
-2,477
| -24% | -$312K |
|
2604
Insight Enterprises
NSIT
$3.71B
| $1.05M | ﹤0.01% |
17,994
-61,875
| -77% | -$3.45M |
|
2605
Monarch Casino & Resort
MCRI
$2.18B
| $1.05M | ﹤0.01% |
24,470
-1,510
| -6% | -$66.1K |
|
|
TRST
2606
Trustco Bank Corp NY
TRST
$978M
| $1.04M | ﹤0.01% |
26,383
+2,235
| +9% | +$86.7K |
|
|
JOYY
2607
CALL
JOYY Inc
JOYY
$3.77B
| $1.04M | ﹤0.01% |
15,000
| – | – |
|
|
PGTI
2608
DELISTED
PGT, Inc.
PGTI
| $1.04M | ﹤0.01% |
62,277
+22,387
| +56% | +$341K |
|
|
CLVS
2609
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.04M | ﹤0.01% |
70,000
| – | – |
|
2610
Inovio Pharmaceuticals
INO
$79.4M
| $1.04M | ﹤0.01% |
29,445
-54,963
| -65% | -$2.18M |
|
|
TLRD
2611
PUT
DELISTED
Tailored Brands, Inc.
TLRD
| $1.04M | ﹤0.01% |
180,000
+100,000
| +125% | +$694K |
|
|
FLNT
2612
Fluent
FLNT
$99.9M
| $1.04M | ﹤0.01% |
32,158
-43,705
| -58% | -$1.54M |
|
2613
Safe Bulkers
SB
$766M
| $1.04M | ﹤0.01% |
664,886
+23,117
| +4% | +$35.9K |
|
2614
Bristow Group
VTOL
$1.37B
| $1.04M | ﹤0.01% |
62,231
-9,607
| -13% | -$172K |
|
2615
Xerox
XRX
$357M
| $1.04M | ﹤0.01% |
29,312
+7,400
| +34% | +$247K |
|
2616
PUT
Genuine Parts
GPC
$17.6B
| $1.04M | ﹤0.01% |
10,000
| – | – |
|
2617
Rockwell Medical
RMTI
$27.6M
| $1.03M | ﹤0.01% |
3,126
+197
| +7% | +$100K |
|
2618
CorVel
CRVL
$3.08B
| $1.03M | ﹤0.01% |
35,583
+10,638
| +43% | +$262K |
|
2619
PUT
Alexandria Real Estate Equities
ARE
$8.96B
| $1.03M | ﹤0.01% |
+7,300
| New | +$1.05M |
|
|
MRTX
2620
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.03M | ﹤0.01% |
+10,000
| New | +$779K |
|
2621
PUT
Agnico Eagle Mines
AEM
$73B
| $1.02M | ﹤0.01% |
20,000
-7,000
| -26% | -$305K |
|
2622
PUT
AppFolio
APPF
$5.98B
| $1.02M | ﹤0.01% |
+10,000
| New | +$945K |
|
2623
Glacier Bancorp
GBCI
$6.38B
| $1.02M | ﹤0.01% |
25,105
+7,552
| +43% | +$310K |
|
2624
Seres Therapeutics
MCRB
$47M
| $1.02M | ﹤0.01% |
15,791
+1,526
| +11% | +$145K |
|
2625
Myers Industries
MYE
$1.23B
| $1.01M | ﹤0.01% |
52,652
+10,164
| +24% | +$183K |
|
Similar funds
D.E. Shaw & Co's Q2 2019 Portfolio in Review
As of Q2 2019, D.E. Shaw & Co held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- D.E. Shaw & Co added most to Alibaba in Q2 2019, an estimated $667M increase.
- D.E. Shaw & Co's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- D.E. Shaw & Co opened 499 new positions and closed 416 in Q2 2019.
- D.E. Shaw & Co's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.